Deep vein thrombosis (DVT) occurs in about 100,000 patients a year in the United Kingdom. Postthrombotic syndrome (PTS) is a major long term complications which develops in about 50% of the patients and is associated with significantly decreased quality of life. Catheter directed thrombolysis (CDT) with stenting of the stenosed segment improves the outcomes.
In total, 165 stents were placed in 73 patients. The median age was 43 years. 44 patients (60.3%) were female and 14 (19%) were diagnosed with a clotting disorder. 79% of patients had a DVT on the left side and in 11% of the cases it was bilateral. 28.8% (21) of the patients required a re-intervention and of those 16 patients required a further procedure. After at least 1 year follow-up primary, primaryassisted and secondary patency were 66%, 85% and 90% respectively.
It is now widely accepted that stenting of significant flow limiting stenoses should be considered to avoid long term complications of proximal DVTs. We have shown that this can be done successfully in 90% of the cases. However, patients should be counselled about a significant rate of re-intervention. Endovenous stents can be used for deep venous reconstruction to treat patients with post-thrombotic syndrome (PTS). Guidelines on iliocaval stenting suggest stenting across the inguinal ligament should be avoided, however stenting from a normal peripheral inflow segment is more important, therefore stenting across the ligament may be necessary. The aim of this study was to examine patency rates when stenting across the inguinal ligament using nitinol venous stents.
Stenting across the inguinal ligament in post thrombotic
Consecutive patients in whom a venous stent was inserted for symptomatic PTS between 2012-2015 were included. All patients had a minimum of one-year follow-up, with pre-operative Villalta scores taken before intervention and at one-year. Patency was assessed peri-operatively using intravascular ultrasound and post-operatively using duplex ultrasonography.
Of 168 patients, 102 (61%) were treated for post-thrombotic obstruction; 94/102 (92%) had a nitinol venous stent of which 71 (76%) crossed the inguinal ligament. Primary, primary-assisted and secondary patency rates were significantly better in stents placed above the inguinal ligament compared with across it (72%, 100%, 100% vs. 52%, 80%, 82%, respectively; P<0.05). There was a significant improvement in Villalta scores of both patients with patent stents in those placed above the inguinal ligament (median improvement of 9 points, range 0-18) and those with stents placed across it (median improvement of 11, range 0-25).
Maintaining stent patency when the stents cross the ligament can be challenging and close surveillance is required as re-intervention may be required. However, nitinol venous stent patency is good at one-year in both groups and significant clinical improvement can be achieved. Our objective was to use live dosimeters to quantify actual radiation exposure to primary operators during endovascular procedures and evaluate the success of our current practice in radiation protection. The limits on effective dose are set out by the Health and Safety Executive (HSE) in the Ionising Radiations Regulations (1999). Employees are limited to 20 millisieverts (mSv -1mSv = 1000μSv) to body or eye in a calendar year, with investigation triggered at 2mSv and the operator becoming a classified worker at 6mSv.
Quantifying potential radiation exposure in real life endovascular cases -implications for practice
The potential radiation dose to primary operators was quantified by monitoring 5 procedures over a 3 week period. These included 3 endovascular aneurysm repairs, 1 aortic cuff and 1 aorto-uni-iliac graft. Phillips live dosimeters were placed in several locations through the operating theatre for the duration of the procedures evaluated.
Cumulative doses for each location are shown in brackets. The locations were as follows: primary operator shin (3017μSv); primary operator chest under leads (2μSv); primary operator chest over leads (13445μSv); inside the lead skirt (3171μSv); and at the radiographer control station (327μSv).
Extrapolating the results to a year-long period for one operator indicates the radiation dose outside leads could reach 200mSv, vastly exceeding HSE limits if lead gowns or eye protection were inadequate. This has consequences for both personal safety and workforce availability due to classified worker restrictions. It is important we recognise this and ensure lead gowns and eye protection are correctly worn and maintained, lead shields and lead skirts used, and film badge dosimeters are worn.
